![Humens logo](/sites/default/files/styles/etudes_thumbs/public/2024-02/logo_Humens.jpg?itok=Sr1RxrBZ)
Stories
Mid-large buyout
Growth
2BSI is a materials and energy recovery specialist operating in niche markets
Infrastructure
StatusIn portfolio
Investment date07/2023
SectorTech-enabled
LocationEurope
Created in 1995 by Philippe Genne, Oncodesign is a biopharmaceutical company specialized in preclinical pharmacological evaluation of new cancer therapies on behalf of pharmaceutical and biotechnology companies
Healthcare - Nov Santé
StatusIn portfolio
Investment date12/2023
SectorHealthcare
LocationEurope
Leader in connected solutions for physiotherapists and sport practitioners
Healthcare - Nov Santé
StatusIn portfolio
Investment date12/2023
SectorHealthcare
LocationEurope
Developer of a conversational AI platform designed to permit companies to build self-learning speech control and cognitive abilities into their applications and connected devices.
Growth
StatusIn portfolio
Investment date06/2024
SectorTech-enabled
LocationEurope
Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)